+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gilead Sciences Inc - logo

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2019 - Product Thumbnail Image

Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2019

  • Report
  • 850 Pages
From
Global Asset Purchase Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014 to 2019 - Product Thumbnail Image

Global Asset Purchase Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014 to 2019

  • Report
  • 550 Pages
From
Global Collaborative R&D Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2014-2019 - Product Thumbnail Image

Global Collaborative R&D Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2014-2019

  • Report
  • 2300 Pages
From
Global Hepatitis C Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025 - Product Thumbnail Image

Global Hepatitis C Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025

  • Report
From
Global Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2014- 2019 - Product Thumbnail Image

Global Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2014- 2019

  • Report
  • 1000 Pages
From
Pancreatic and Bile Duct Cancer Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Pancreatic and Bile Duct Cancer Drug Development Pipeline Review, 2018

  • Report
  • 385 Pages
From
Global Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014 to 2019 - Product Thumbnail Image

Global Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014 to 2019

  • Report
  • 900 Pages
From
TCR Engineered T-Cell Therapy 2018: An Industry Analysis of Technologies, Pipelines, Stakeholders & Deals - Product Thumbnail Image

TCR Engineered T-Cell Therapy 2018: An Industry Analysis of Technologies, Pipelines, Stakeholders & Deals

  • Report
  • 294 Pages
From
Global Hepatitis B Virus [HBV] Treatment Market - Analysis By Type (Therapeutics, Vaccine), By End User (Male, Female) - By Region, By Country: Opportunities and Forecast (2017-2022) - Product Thumbnail Image

Global Hepatitis B Virus [HBV] Treatment Market - Analysis By Type (Therapeutics, Vaccine), By End User (Male, Female) - By Region, By Country: Opportunities and Forecast (2017-2022)

  • Report
  • 180 Pages
From
Global HIV Infection Drug Market & Pipeline Insight - Product Thumbnail Image

Global HIV Infection Drug Market & Pipeline Insight

  • Drug Pipelines
  • 1350 Pages
From
Global Hepatitis Drug Market & Clinical Trials Insight 2023 - Product Thumbnail Image

Global Hepatitis Drug Market & Clinical Trials Insight 2023

  • Report
  • 550 Pages
From
HIV Drug Market by Medication class - Global Opportunity Analysis and Industry Forecast, 2014-2022 - Product Thumbnail Image

HIV Drug Market by Medication class - Global Opportunity Analysis and Industry Forecast, 2014-2022

  • Report
  • 163 Pages
From
Intracellular Targets Made Druggable by TCR-like Antibodies, TCR Fusion Proteins & Cell-Penetrating Biologics 2018: An Industry Analysis of Technologies, Stakeholders, Deals & Trends - Product Thumbnail Image

Intracellular Targets Made Druggable by TCR-like Antibodies, TCR Fusion Proteins & Cell-Penetrating Biologics 2018: An Industry Analysis of Technologies, Stakeholders, Deals & Trends

  • Report
  • 252 Pages
From
Global Royalty Rate Trends in Pharma and Biotech Dealmaking 2014-2019 - Product Thumbnail Image

Global Royalty Rate Trends in Pharma and Biotech Dealmaking 2014-2019

  • Report
  • 200 Pages
From
Global Cancer Monoclonal Antibodies Market & Pipeline Insight - Product Thumbnail Image

Global Cancer Monoclonal Antibodies Market & Pipeline Insight

  • Drug Pipelines
  • 1400 Pages
From
Large Volume Wearable Injectors Market (4th Edition), 2018-2030 - Product Thumbnail Image

Large Volume Wearable Injectors Market (4th Edition), 2018-2030

  • Report
  • 348 Pages
From
Global Biologics Drug Discovery Market Analysis and Forecast, 2017-2025: Focus on Method/Phase, Product Type, Manufacturer Type and Competitive Landscape - Product Thumbnail Image

Global Biologics Drug Discovery Market Analysis and Forecast, 2017-2025: Focus on Method/Phase, Product Type, Manufacturer Type and Competitive Landscape

  • Report
  • 358 Pages
From
Hepatitis Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018-2026 - Product Thumbnail Image

Hepatitis Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018-2026

  • Report
  • 183 Pages
From
Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2024, NAIC 325412 - Product Thumbnail Image

Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2024, NAIC 325412

  • Report
  • 73 Pages
From
Hepatitis C Treatment - Market Analysis, Trends, and Forecasts - Product Thumbnail Image

Hepatitis C Treatment - Market Analysis, Trends, and Forecasts

  • Report
  • 155 Pages
From
Loading Indicator
adroll